PATENT CLAIM ANALYSIS

Application Number: 15961112
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-09
Patent Classification: ["424", "449000"]

Abstract:
Disclosed herein is a transdermal delivery system comprising methylphenidate or its salt as an active ingredient. Also provided are methods of delivering a therapeutically effective amount of methylphenidate to a subject for the treatment of a disease condition. The disease condition includes a neurological condition such as Attention Deficit Disorder (ADD) and/or Attention Deficit/Hyperactivity Disorder (ADHD). Kits including the transdermal delivery system and methods of making and using the transdermal delivery system are also provided.

Claim (Index 7):
The transdermal delivery system of  claim 1  wherein the silicone adhesive layer comprises 100% of silicone adhesive.

Metadata:
- Claim Count in Document: 4.0
- Percentile: 91.0
- Lexical Diversity: 1.59615
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15961335', '15634188', '14381627', '14052190', '14893020']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7361547125878544
- 35 USC 102 Novelty (BERT): 0.576324574258759
- Combined Prediction Score: 0.7201716987549448
- Mean Citation Score: 339.3727140000001
- Max Citation Score: 480.04404000000005
- Similarity Product: 365.4021176918936

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test